XCel Brands Inc

For the period ended Dec 31, 2023. Filed Apr 19, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 19, 2024

XELB$0.43+6.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)


· · Xcel Brands, Inc. Stockholders · · · · · ·
· · Common Stock · · Paid-in · · Accumulated · · Noncontrolling · · ·
· Shares · Amount · Capital · Deficit · Interest · Total
Balance as of January 1, 2022	19,571,119	20	103,039	(28,779)	662	74,942

Compensation expense related to stock options and restricted stock	—	—	534	—	—	534

Shares issued to executive in connection with stock grants for bonus payments	178,727	—	281	—	—	281

Shares repurchased from executive in exchange for withholding taxes	(53,882)	—	(85)	—	—	(85)

Shares issued to directors in connection with restricted stock grants	50,000	—	—	—	—	—

Shares issued to consultants in connection with stock grants	20,064	—	33	—	—	33

Shares issued to consultant in connection with sale transaction (see Note 3 and Note 7)	65,275	—	97	—	—	97

Shares issued to key employee in connection with stock grant	33,557	—	50	—	—	50

Shares repurchased from key employee in exchange for withholding taxes related to vesting of restricted shares	(240,000)	—	(357)	—	—	(357)

Net loss for the year ended December 31, 2022	—	—	—	(4,018)	(1,338)	(5,356)

Balance as of December 31, 2022	19,624,860	20	103,592	(32,797)	(676)	70,139

Compensation expense related to stock options and restricted stock	—	—	161	—	—	161

Contra-revenue related to warrants granted to licensee	—	—	26	—	—	26

Shares issued to directors in connection with restricted stock grants	40,000	—	—	—	—	—

Forfeitures of restricted stock grants	(5,000)	—	—	—	—	—

Shares issued to consultant in connection with stock grants	66,668	—	45	—	—	45

Shares issued to employee in connection with stock grant	7,300	—	10	—	—	10

Shares issued on exercises of stock options, net of shares surrendered for cashless exercises	61,225	—	27	—	—	27

Net loss for the year ended December 31, 2023	—	—	—	(21,052)	(1,185)	(22,237)

Balance as of December 31, 2023	19,795,053	$20	$103,861	$(53,849)	$(1,861)	$48,171

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.